drugset / Trial / NCT01905501

Sevoflurane Protective Effect on Ischemia-reperfusion Injury. Multicenter, Randomized Controlled Trial

NCT01905501

Completed 132 enrolled Regina Elena Cancer Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aimed to evaluate the possible protective effect of anesthetic technique balanced(with sevoflurane) compared with total intravenous anesthetic technique (propofol,remifentanil). The hypothesis is that the Sevoflurane may exert protective effect in regard to the ischemia-reperfusion injury induced on the microsurgical breast free flap during transfer to receiving area. The investigators will evaluate the continuous flap tissue oximetry and the level of biochemical markers.

Timeline

Start
2013-02
Primary completion
2014-09
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 3 ug/ml Intravenous
Comparator Propofol Small molecule 4 ug/ml Intravenous
Subject Sevoflurane Other / unclassified 1.8 % Inhaled
Subject Sevoflurane Other / unclassified 2 % Inhaled
Comparator Remifentanil Small molecule 1 ng/ml Intravenous
Comparator Remifentanil Small molecule 3 ng/ml Intravenous

Indications

No indication recorded.